MUC1-C activates BMI1 in human cancer cells

M. Hiraki, T. Maeda, A. Bouillez, M. Alam, A. Tagde, K. Hinohara, Y. Suzuki, T. Markert, M. Miyo, K. Komura, R. Ahmad, H. Rajabi, D. Kufe

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overexpressed in human carcinoma cells and has been linked to their self-renewal. There is no known relationship between MUC1-C and BMI1 in cancer. The present studies demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism in breast and other cancer cells. In addition, we show that MUC1-C blocks miR-200c-mediated downregulation of BMI1 expression. The functional significance of this MUC1-Câ †'ï BMI1 pathway is supported by the demonstration that targeting MUC1-C suppresses BMI1-induced ubiquitylation of H2A and thereby derepresses homeobox HOXC5 and HOXC13 gene expression. Notably, our results further show that MUC1-C binds directly to BMI1 and promotes occupancy of BMI1 on the CDKN2A promoter. In concert with BMI1-induced repression of the p16 INK4a tumor suppressor, we found that targeting MUC1-C is associated with induction of p16 INK4a expression. In support of these results, analysis of three gene expresssion data sets demonstrated highly significant correlations between MUC1-C and BMI1 in breast cancers. These findings uncover a previously unrecognized role for MUC1-C in driving BMI1 expression and in directly interacting with this stem cell factor, linking MUC1-C with function of the PRC1 in epigenetic gene silencing.

Original languageEnglish
Pages (from-to)2791-2801
Number of pages11
JournalOncogene
Volume36
Issue number20
DOIs
Publication statusPublished - May 18 2017
Externally publishedYes

Fingerprint

Mucin-1
Neoplasms
Polycomb Repressive Complex 1
Breast Neoplasms
Virus Integration
Moloney murine leukemia virus
Stem Cell Factor
Neoplastic Stem Cells
Homeobox Genes
Ubiquitination
Gene Silencing
Epigenomics
B-Lymphocytes
Down-Regulation

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Hiraki, M., Maeda, T., Bouillez, A., Alam, M., Tagde, A., Hinohara, K., ... Kufe, D. (2017). MUC1-C activates BMI1 in human cancer cells. Oncogene, 36(20), 2791-2801. https://doi.org/10.1038/onc.2016.439

MUC1-C activates BMI1 in human cancer cells. / Hiraki, M.; Maeda, T.; Bouillez, A.; Alam, M.; Tagde, A.; Hinohara, K.; Suzuki, Y.; Markert, T.; Miyo, M.; Komura, K.; Ahmad, R.; Rajabi, H.; Kufe, D.

In: Oncogene, Vol. 36, No. 20, 18.05.2017, p. 2791-2801.

Research output: Contribution to journalArticle

Hiraki, M, Maeda, T, Bouillez, A, Alam, M, Tagde, A, Hinohara, K, Suzuki, Y, Markert, T, Miyo, M, Komura, K, Ahmad, R, Rajabi, H & Kufe, D 2017, 'MUC1-C activates BMI1 in human cancer cells', Oncogene, vol. 36, no. 20, pp. 2791-2801. https://doi.org/10.1038/onc.2016.439
Hiraki M, Maeda T, Bouillez A, Alam M, Tagde A, Hinohara K et al. MUC1-C activates BMI1 in human cancer cells. Oncogene. 2017 May 18;36(20):2791-2801. https://doi.org/10.1038/onc.2016.439
Hiraki, M. ; Maeda, T. ; Bouillez, A. ; Alam, M. ; Tagde, A. ; Hinohara, K. ; Suzuki, Y. ; Markert, T. ; Miyo, M. ; Komura, K. ; Ahmad, R. ; Rajabi, H. ; Kufe, D. / MUC1-C activates BMI1 in human cancer cells. In: Oncogene. 2017 ; Vol. 36, No. 20. pp. 2791-2801.
@article{6d8aeae616714fc9b454476100c6d123,
title = "MUC1-C activates BMI1 in human cancer cells",
abstract = "B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overexpressed in human carcinoma cells and has been linked to their self-renewal. There is no known relationship between MUC1-C and BMI1 in cancer. The present studies demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism in breast and other cancer cells. In addition, we show that MUC1-C blocks miR-200c-mediated downregulation of BMI1 expression. The functional significance of this MUC1-C{\^a} †'{\"i} BMI1 pathway is supported by the demonstration that targeting MUC1-C suppresses BMI1-induced ubiquitylation of H2A and thereby derepresses homeobox HOXC5 and HOXC13 gene expression. Notably, our results further show that MUC1-C binds directly to BMI1 and promotes occupancy of BMI1 on the CDKN2A promoter. In concert with BMI1-induced repression of the p16 INK4a tumor suppressor, we found that targeting MUC1-C is associated with induction of p16 INK4a expression. In support of these results, analysis of three gene expresssion data sets demonstrated highly significant correlations between MUC1-C and BMI1 in breast cancers. These findings uncover a previously unrecognized role for MUC1-C in driving BMI1 expression and in directly interacting with this stem cell factor, linking MUC1-C with function of the PRC1 in epigenetic gene silencing.",
author = "M. Hiraki and T. Maeda and A. Bouillez and M. Alam and A. Tagde and K. Hinohara and Y. Suzuki and T. Markert and M. Miyo and K. Komura and R. Ahmad and H. Rajabi and D. Kufe",
year = "2017",
month = "5",
day = "18",
doi = "10.1038/onc.2016.439",
language = "English",
volume = "36",
pages = "2791--2801",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "20",

}

TY - JOUR

T1 - MUC1-C activates BMI1 in human cancer cells

AU - Hiraki, M.

AU - Maeda, T.

AU - Bouillez, A.

AU - Alam, M.

AU - Tagde, A.

AU - Hinohara, K.

AU - Suzuki, Y.

AU - Markert, T.

AU - Miyo, M.

AU - Komura, K.

AU - Ahmad, R.

AU - Rajabi, H.

AU - Kufe, D.

PY - 2017/5/18

Y1 - 2017/5/18

N2 - B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overexpressed in human carcinoma cells and has been linked to their self-renewal. There is no known relationship between MUC1-C and BMI1 in cancer. The present studies demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism in breast and other cancer cells. In addition, we show that MUC1-C blocks miR-200c-mediated downregulation of BMI1 expression. The functional significance of this MUC1-Câ †'ï BMI1 pathway is supported by the demonstration that targeting MUC1-C suppresses BMI1-induced ubiquitylation of H2A and thereby derepresses homeobox HOXC5 and HOXC13 gene expression. Notably, our results further show that MUC1-C binds directly to BMI1 and promotes occupancy of BMI1 on the CDKN2A promoter. In concert with BMI1-induced repression of the p16 INK4a tumor suppressor, we found that targeting MUC1-C is associated with induction of p16 INK4a expression. In support of these results, analysis of three gene expresssion data sets demonstrated highly significant correlations between MUC1-C and BMI1 in breast cancers. These findings uncover a previously unrecognized role for MUC1-C in driving BMI1 expression and in directly interacting with this stem cell factor, linking MUC1-C with function of the PRC1 in epigenetic gene silencing.

AB - B-cell-specific Moloney murine leukemia virus integration site 1 (BMI1) is a component of the polycomb repressive complex 1 (PRC1) complex that is overexpressed in breast and other cancers, and promotes self-renewal of cancer stem-like cells. The oncogenic mucin 1 (MUC1) C-terminal (MUC1-C) subunit is similarly overexpressed in human carcinoma cells and has been linked to their self-renewal. There is no known relationship between MUC1-C and BMI1 in cancer. The present studies demonstrate that MUC1-C drives BMI1 transcription by a MYC-dependent mechanism in breast and other cancer cells. In addition, we show that MUC1-C blocks miR-200c-mediated downregulation of BMI1 expression. The functional significance of this MUC1-Câ †'ï BMI1 pathway is supported by the demonstration that targeting MUC1-C suppresses BMI1-induced ubiquitylation of H2A and thereby derepresses homeobox HOXC5 and HOXC13 gene expression. Notably, our results further show that MUC1-C binds directly to BMI1 and promotes occupancy of BMI1 on the CDKN2A promoter. In concert with BMI1-induced repression of the p16 INK4a tumor suppressor, we found that targeting MUC1-C is associated with induction of p16 INK4a expression. In support of these results, analysis of three gene expresssion data sets demonstrated highly significant correlations between MUC1-C and BMI1 in breast cancers. These findings uncover a previously unrecognized role for MUC1-C in driving BMI1 expression and in directly interacting with this stem cell factor, linking MUC1-C with function of the PRC1 in epigenetic gene silencing.

UR - http://www.scopus.com/inward/record.url?scp=84997766152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84997766152&partnerID=8YFLogxK

U2 - 10.1038/onc.2016.439

DO - 10.1038/onc.2016.439

M3 - Article

C2 - 27893710

AN - SCOPUS:84997766152

VL - 36

SP - 2791

EP - 2801

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 20

ER -